BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5170343)

  • 1. [Kinetic studies on human myeloma cells following melphalan administration].
    Hara H; Nakai K; Nagai K
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):614-21. PubMed ID: 5170343
    [No Abstract]   [Full Text] [Related]  

  • 2. Anit-immunoglobulins in multiple myeloma.
    Abdou NI; Abdou NL
    Clin Exp Immunol; 1972 May; 11(1):57-65. PubMed ID: 4537698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
    Alberts DS; Golde DW
    Cancer Res; 1974 Nov; 34(11):2911-4. PubMed ID: 4424360
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling index.
    Boccadoro M; Massaia M; Dianzani U; Pileri A
    Haematologica; 1987; 72(2):171-5. PubMed ID: 3114074
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro determination of myeloma cell resistance to melphalan using the 3H-thymidine incorporation technique.
    Gola A; Kuliczkowski K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):167-72. PubMed ID: 1695172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetical and clinico-hematological changes in myeloma disease].
    Dubrova SE; Dygin VP; Ushakova EA
    Tsitologiia; 1966; 8(2):241-9. PubMed ID: 5984072
    [No Abstract]   [Full Text] [Related]  

  • 7. The phagocytic plasma cells.
    Abramson N; von Kapff C; Ginsburg AD
    N Engl J Med; 1970 Jul; 283(5):248-50. PubMed ID: 5424734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protein synthesis of plasma cells in myeloma and its relationship to the reduced proliferative activity].
    Eridani S; Astaldi G; Ponti GB
    Haematol Lat; 1969; 12(3):507-14. PubMed ID: 5396821
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloma cell resistance to melphalan, BCNU and epirubicin determined in vitro with the 3H-thymidine incorporation technique prior to chemotherapy.
    Gola A; Kuliczkowski K; Sedek K
    Neoplasma; 1992; 39(1):35-8. PubMed ID: 1528303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo kinetic studies in human myeloma.
    Pileri A; Tarocco RP
    Haematologica; 1974 Mar; 59(1):10-24. PubMed ID: 4137723
    [No Abstract]   [Full Text] [Related]  

  • 12. Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature.
    Hütter G; Nowak D; Blau IW; Thiel E
    Int J Lab Hematol; 2009 Apr; 31(2):236-40. PubMed ID: 18190590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of recent studies of cellular proliferation in acute leukemia.
    Clarkson BD
    Natl Cancer Inst Monogr; 1969 May; 30():81-120. PubMed ID: 5260445
    [No Abstract]   [Full Text] [Related]  

  • 14. The generation time of human leukemic myeloblasts.
    Greenberg ML; Chanana AD; Cronkite EP; Giacomelli G; Schiffer LM; Stryctmans PA; Vincent PC
    Lab Invest; 1972 Mar; 26(3):245-52. PubMed ID: 4502025
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma cells of the bone marrow in myelomatosis treated with Alkeran (melphalan).
    Axelsson U
    Scand J Haematol; 1966; 3(2):123-35. PubMed ID: 5946776
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential therapy compared with combination therapy in multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refractory anemia with partial myeloblastosis in multiple myeloma treated with melphalan].
    Morlock G; Bataille R; Sany J; Serre H
    Sem Hop; 1977 Apr 9-16; 53(14-15):853-6. PubMed ID: 194338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Silent onset of multiple myeloma. How to diagnosis and when to treat?].
    Bartl R
    Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular kinetics staging, and immunoglobulin synthesis in multiple myeloma.
    Durie BG; Salmon SE
    Annu Rev Med; 1975; 26():283-8. PubMed ID: 1096765
    [No Abstract]   [Full Text] [Related]  

  • 20. Early plasma cell recruitment in multiple myeloma following chemotherapy.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R
    Cell Tissue Kinet; 1988 Nov; 21(6):405-9. PubMed ID: 3251633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.